NCT00138983View on ClinicalTrials.gov

Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.

PHASE3CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

May 31, 2000

Study Completion Date

November 30, 2003

Conditions

Rheumatoid ArthritisPolymyalgia RheumaticaGiant Cell ArteritisPolymyositisWegener's Granulomatosis

Interventions

DRUG

Alendronate versus alfacalcidol (1-alpha OH vitamin D)

Trial Locations (1)

3584 CX

UMC Utrecht, Utrecht

All Listed Sponsors

collaborator

Dutch Health Care Insurance Board

OTHER

lead

UMC Utrecht

OTHER

NCT00138983 - Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol. | Biotech Hunter | Biotech Hunter